Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclogest dose-regimen PK/PD comparison versus Crinone and placebo
NL-OMON37494Active, not recruiting
- Sponsor
- Allergan
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of progesterone in infertility and luteal insufficiency (3 arms), sponsored by Allergan. Primary endpoint: Secretory transformation of the endometrium. Started May 2012; status: active, not recruiting.
02
Drugs
progesterone
03
Conditions
infertilityluteal insufficiency
Beyond the preview
Go deeper on NL-OMON37494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37494.